1. Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12
   Zhi Guo et al, 2016 CrossRef
2. Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest
   Sujin Kang et al, 2015, Cellular Signalling CrossRef
3. Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes.
   , 2017, BMC Cancer CrossRef
4. An image cytometric technique is a concise method to detect adenoviruses and host cell proteins and to monitor the infection and cellular responses induced
   Takao Morinaga et al, 2017, Virol J CrossRef
5. A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy
   Ming Yang et al, 2017, Cancer Biology & Therapy CrossRef
6. Establishment of a mouse melanoma model system for the efficient infection and replication of human adenovirus type 5-based oncolytic virus
   Sujin Kang et al, 2014, Biochemical and Biophysical Research Communications CrossRef
7. Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells.
   Dongxu Kang et al, 2015, Cell. Signal. CrossRef
8. Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells
   Zhezhu Han et al, 2016, Apoptosis CrossRef
9. High levels of Daxx due to low cellular levels of HSP25 in murine cancer cells result in inefficient adenovirus replication
   Zhezhu Han et al, 2019, Exp Mol Med CrossRef
10. Prime-boost immunization by both DNA vaccine and oncolytic adenovirus expressing GM-CSF and shRNA of TGF-β2 induces anti-tumor immune activation
    So Young Kim et al, 2017, Oncotarget CrossRef
11. Crosstalk between oncolytic viruses and autophagy in cancer therapy
    Ke-Tao Jin et al, 2021, Biomedicine & Pharmacotherapy CrossRef
12. Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer
    Ali Zahedi-Amiri et al, 2021, Cells CrossRef
13. A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition
    Abtin Behmardi et al, 2022, Drug Deliv. and Transl. Res. CrossRef
14. Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors
    Yinghan Su et al, 2022, J Immunother Cancer CrossRef
15. Current landscape and perspective of oncolytic viruses and their combination therapies
    Yinghan Su et al, 2022, Translational Oncology CrossRef
16. Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
    Zhi Zhu et al, 2022, Mol Cancer CrossRef
17. Expanding the Scope of Adenoviral Vectors by Utilizing Novel Tools for Recombination and Vector Rescue
    Julian Fischer et al, 2024, Viruses CrossRef